Shanghai Heyuan Private Equity New Products has raised more than 5 billion yuan, and the scale of the first fundraising is expected to continue to rise

On June 29, Capital State learned that the new product "Heyuan Yuhong Series Fund" issued by Shanghai Heyuan Private Equity Fund Management Co., Ltd. (hereinafter referred to as "Shanghai Heyuan Private Equity") is being released on the sales channels of various funds. 1 million yuan, 3 million yuan and 10 million yuan are available, and the lock -up period is one year. The latest news shows that the cumulative sales of this product have exceeded 5 billion yuan.

The company's official website shows that Shanghai Heyuan Private Equity was established in March 2022 and completed the registration and filing of the China Securities Investment Fund Industry Association on May 13. The company focuses on investing in secondary market stocks, mainly covered by: pharmaceuticals, medical care, large consumption, new chemical materials, new energy, machinery, electronic technology TMT and other directions, focusing on long -term opportunities to have significant growth industries. Guan Huayu is the general manager and fund manager of Shanghai Heyuan Private Equity. He has the successful experience of public offering and private equity. He used to be the investment director and research director of the rights and interests of a public fund.

Guan Huayu's first show was dazzling after the founding of Shanghai Heyuan private equity, or due to the recent market rebound, investor confidence has rebounded, or it may be because of the results of the fund manager's past performance or other factors. At present, the "Heyuan Yuhong Series Fund" is still in the raising period, and it does not rule out the possibility of continuing the future fundraising scale.

- END -